Rigid Endoscopes Market Analysis

Rigid Endoscopes Market Analysis

Based on product, the rigid endoscopes market is segmented as laparoscopes, arthroscopes, cystoscopes, ENT endoscopes, pulmonary endoscopes, and others. The laparoscopes segment held the dominant market share in 2022 and was valued at over USD 3.3 billion. This largest business share is majorly attributable to the surging prevalence of chronic ailments and increasing patient volume suffering from abdominal pain. Rigid laparoscopes are used to diagnose and treat acute & chronic abdominal pain. Appendicitis, intra-abdominal scar tissue, pelvic infections, endometriosis, abdominal haemorrhage, and other severe diseases require laparoscopy.
 

Endometriosis is one of the leading causes of abdominal pain among women that requires laparoscopy. For instance, according to the reports published by the World Health Organization (WHO), in 2021, around 190 million females globally suffered from endometriosis that accounted for around 10% of the female population. The rising prevalence of such conditions is expected to drive the visits at hospitals & ambulatory surgical centers for diagnosis & treatment. Therefore, the demand for laparoscopic instruments is expected to grow at a steady pace due to aging population and rising incidences of gastrointestinal disorders. Thus, the rising prevalence along with aging population is set to drive the patient volume in healthcare settings, thereby boosting the demand for rigid laparoscope significantly.
 

Based on technology, the rigid endoscopes market is segmented as conventional endoscopes, video endoscopes, and fiber-optic endoscopes. The video endoscopes segment accounted for a dominant market share in 2022 and was valued at over USD 5.0 billion. This high market share is owing to increasing demand and surging awareness pertaining to advantages delivered by rigid video endoscopes in the early-stage diagnosis of multiple chronic health conditions comprising stomach pain, ulcers, gastritis, digestive tract bleeding, etc. These rigid video endoscopes are highly used in endoscopy procedures as it enables endoscopic examination of the esophagus and offers a mobile & convenient solution for hospitals among others.
 

The video endoscopes are intended to aid the physicians or endoscopists for diagnostic & therapeutic procedures in endoscopy, endotracheal intubation, etc. The increasing prevalence of liver diseases such as gastroesophageal reflux disorder (GERD), biliary disease, and Crohn’s disease among others is stimulating the adoption of these products. For instance, as per the recent data, around 5.5 million people in the U.S. have chronic liver disease or cirrhosis. Furthermore, rising awareness related to devices used in endoscopy procedures for the treatment of these diseases assists in boosting business growth. As a result, several clinical advantages delivered by the rigid video endoscope are projected to fuel the market growth positively.
 

Based on usability, the rigid endoscopes market is segmented as reusable endoscopes and disposable endoscopes. The disposable rigid endoscopes segment held a notable market share in 2022 and was valued at around USD 2.9 billion. The rising demand for disposable rigid endoscopes in various healthcare facilities including hospitals, ACSs, and clinics is set to accelerate the segmental growth. These products are single use rigid endoscopes and discarded immediately after use. Disposable endoscopes curb cross-contamination with patients and practitioners, thereby preventing the spread of pathogenic microbes and other infection from external sources. These products are highly advantageous and also protect against a set of threats, including biohazards, pathogens such as bacteria and viruses, and other chemicals.
 

Furthermore, increasing awareness regarding health safety along with growing number of surgeries are further fostering the demand for disposable rigid endoscopes. Therefore, the aforementioned factors are set to influence the demand for disposable rigid endoscopes and expected to witness lucrative growth in rigid endoscopes industry in the coming years.
 

Based on end-use, the rigid endoscopes market is segmented as hospitals, ambulatory surgical centers, clinics, Others. The hospitals segment is projected to reach more than USD 7.7 billion by 2032. This majority market share is owing to the soaring use of novel rigid endoscopes in hospital settings offering enhanced operability is estimated to surge the patient preference for hospitals. Increasing admissions with target disorders due to sedentary lifestyle and growing disease screening initiatives coupled with the availability of highly skilled healthcare professionals are some other attributes that are propelling the growth of the hospitals segment positively.
 

Additionally, the higher chronic disease incidence in developed nations with robust healthcare infrastructure is anticipated to positively impact the segment growth. Surging cancer cases, infections, and metabolic disease prevalence will significantly propel the diagnosis & treatment rate at hospitals. Thus, accessibility to better treatment & diagnosis coupled with the rising prevalence of these ailments and associated conditions is estimated to boost patient visits to hospitals, thereby propelling the segment revenue.
 

U.S. dominated the North America rigid endoscopes market with a significant market share in 2022 and is anticipated to expand at a considerable pace to reach around USD 6.7 billion by 2032. This significant market share is attributable to several factors such as the presence of major business players, surging demand for the product, etc. The presence of prominent players such as Boston Scientific Corporation, Olympus Corporation, and Karl Storz among others are engaged in the new product development & commercialization that facilitates the industrial expansion in the country. The high prevalence of gastrointestinal diseases and the rising hospital admission in the region emphasize the growing need for rigid endoscopes in related procedures. As per the National Ambulatory Medical Care recent survey, over 40 million patients had performed diagnosis for diseases of the digestive systems in the U.S.